M. Cushman

Publication List Details

Period

1992 - 2008

Number

50

Co-Authors

Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors (2008)

Cullen, M.D., Cheung, Y.F., Houslay, M.D., Hartman, T.L., Watson, K.M., Buckheit, R.W., ...

The alkenyldiarylmethanes (ADAMs) are currently being investigated as non- nucleoside HIV- 1 reverse transcriptase inhibitors (NNRTIs) of potential value in the treatment of HIV infection and AIDS....

Psychosocial Factors and Inflammation in the Multi-Ethnic Study of Atherosclerosis (2007)

Ranjit, N, Diez Roux, AV, Shea, S, Cushman, M, Seeman, T

Background Psychosocial factors are associated with the development and progress of cardiovascular disease, but the pathological mechanisms remain unclear. We examined the associations of...

Socioeconomic position, race/ethnicity and inflammation in the Multi-Ethnic Study of Atherosclerosis (2007)

Ranjit, N, Diez Roux, AV, Shea, S, Cushman, M, Ni, H, Seeman, T

Background— Low socioeconomic position is known to be associated with cardiovascular events and atherosclerosis. Reasons for these associations remain a topic of research. Inflammation could be an...

Recent exposure to particulate matter and C-reactive protein concentration in the Multiethnic Study of Atherosclerosis (MESA) (2006)

Diez Roux, AV, Auchincloss, A, Astor, B, Barr, RG, Cushman, M, Dvonch, T, ...

http://deepblue.lib.umich.edu/bitstream/2027.42/55422/1/Diez Roux et al Sep 2006 Recent exposure to particulate matter and C-reactive protein concentration in the multi-ethnic study of...

Recent Exposure to Particulate Matter and C-reactive Protein Concentration in the Multi-Ethnic Study of Atherosclerosis (2006)

Diez Roux, A. V., Auchincloss, A. H., Astor, B., Barr, R. G., Cushman, M., Dvonch, T., ...

Ambient levels of particulate matter have been linked to cardiovascular disease. The mechanisms mediating these associations are poorly understood. One candidate mechanism is inflammation. Using data...

Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease (2004)

Kostis, J.B., Wilson, A.C., Folsom, A.R., Chambless, L., Wu, K., Benderly, M., ...

Background Many long-term studies have reported on associations of plasma fibrinogen concentration with cardiovascular disease, but few have been large enough to provide reliable estimates in...

Incorporation of an amide into 5-phosphonoalkyl-6-D- ribitylaminopyrimidinedione lumazine synthase inhibitors results in an unexpected reversal of selectivity for riboflavin synthase vs lumazine synthase (2002)

Cushman,M., Yang,D. L., Mihalic,J. T., Chen,J. H., Gerhardt,S., Huber,R., ...

Several analogues of a hypothetical intermediate in the reaction catalyzed by lumazine synthase were synthesized and tested as inhibitors of both Bacillus subtilis lumazine synthase and Escherichia...

Studies on the reaction mechanism of riboflavin synthase: X-ray crystal structure of a complex with 6-carboxyethyl-7-oxo-8- ribityllumazine (2002)

Gerhardt,S., Schott,A. K., Kairies,N., Cushman,M., Illarionov,B., Eisenreich,W., ...

Riboflavin synthase catalyzes the disproportionation of 6,7- dimethyl-8-ribityllumazine affording riboflavin and 5-amino-6- ribitylamino-2,4(1H,3H)-pyrimidinedione. We have determined the structure...

Design, synthesis, and evaluation of 6-carboxyalkyl and 6- phosphonoxyalkyl derivatives of 7-oxo-8-ribitylaminolumazines as inhibitors of riboflavin synthase and lumazine synthase (2002)

Cushman,M., Yang,D. L., Gerhardt,S., Huber,R., Fischer,M., Kis,K., ...

A series of 6-carboxyalkyl and 6-phosphonoxyalkyl derivatives of 7-oxo-8-D-ribityllumazine were synthesized as inhibitors of both Escherichia coli riboflavin synthase and Bacillus subtilis lumazine...

Incorporation of an amide into 5-phosphonoalkyl-6-D- ribitylaminopyrimidinedione lumazine synthase inhibitors results in an unexpected reversal of selectivity for riboflavin synthase vs lumazine synthase (2002)

Cushman, M., Yang, D. L., Mihalic, J. T., Chen, J. H., Gerhardt, S., Huber, R., ...

Several analogues of a hypothetical intermediate in the reaction catalyzed by lumazine synthase were synthesized and tested as inhibitors of both Bacillus subtilis lumazine synthase and Escherichia...

Design, synthesis, and evaluation of 6-carboxyalkyl and 6- phosphonoxyalkyl derivatives of 7-oxo-8-ribitylaminolumazines as inhibitors of riboflavin synthase and lumazine synthase (2002)

Cushman, M., Yang, D. L., Gerhardt, S., Huber, R., Fischer, M., Kis, K., ...

A series of 6-carboxyalkyl and 6-phosphonoxyalkyl derivatives of 7-oxo-8-D-ribityllumazine were synthesized as inhibitors of both Escherichia coli riboflavin synthase and Bacillus subtilis lumazine...

Studies on the reaction mechanism of riboflavin synthase: X-ray crystal structure of a complex with 6-carboxyethyl-7-oxo-8- ribityllumazine (2002)

Gerhardt, S., Schott, A. K., Kairies, N., Cushman, M., Illarionov, B., Eisenreich, W., ...

Riboflavin synthase catalyzes the disproportionation of 6,7- dimethyl-8-ribityllumazine affording riboflavin and 5-amino-6- ribitylamino-2,4(1H,3H)-pyrimidinedione. We have determined the structure...

Synthesis and anti-HIV activity of cosalane analogues incorporating two dichlorodisalicylmethane pharmacophore fragments (2001)

Loftus, T L, Turpin, J A, ...

A new series of cosalane analogues incorporating two fragments of the dichlorodisalicylmethane pharmacophore has been synthesized. In order to identify the position for the attachment of the...

Correlation of anti-HIV activity with anion spacing in a series of cosalane analogues with extended polycarboxylate pharmacophores (2001)

Paul, G C, Loftus, T L, ...

Cosalane and its synthetic derivatives inhibit the binding of gp120 to CD4 as well as the fusion of the viral envelope with the cell membrane. The binding of the cosalanes to CD4 is proposed to...

Synthesis and anti-HIV activity of a bile acid analog of cosalane (2001)

Hartman, T, Turpin, J, ...

Cosalane is a novel anti-HIV agent that inhibits the attachment of gp120 to CD4. The therapeutic potential of cosalane is limited by poor oral absorption. In an attempt to target the ileal bile acid...

Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates (2000)

Loftus, T L, Turpin, J A, ...

The binding of the anti-HIV agent cosalane to CD4 is thought to involve ionic interactions of negatively charged carboxylates of the ligand with positively charged residues on the surface of the...

Synthesis and anti-HIV activity of cosalane analogues incorporating nitrogen in the linker chain (2000)

Stup, T L, Turpin, J A, ...

Introduction of an amido group or an amino moiety into the alkenyl linker chain of cosalane (1) provided a new series of analogues 3-8. The new compounds were evaluated as inhibitors of the...

Synthesis and anti-HIV activity of cosalane analogues with substituted benzoic acid rings attached to the pharmacophore through methlylene and amide linkers (1999)

Stup, TL, Turpin, JA, ...

The cosalane pharmacophore has been extended by the attachment of two additional substituted benzoic acid rings through amide and methylene linkers. The resulting compounds display significant...

Mechanism of the antiviral activity of new aurintricarboxylic acid analogues (1996)

Esté, JA, Cushman, M, ...

Various new aurintricarboxylic acid (ATA) polymer analogues have been evaluated for their antiviral activity against a wide array of DNA and RNA viruses, and their mechanism of action against human...

Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease

Kostis, J.B., Wilson, A.C., Folsom, A.R., Chambless, L., Wu, K., Benderly, M., ...

Background Many long-term studies have reported on associations of plasma fibrinogen concentration with cardiovascular disease, but few have been large enough to provide reliable estimates in...

Production and antibacterial activity of malforming C, a toxic metabolite of Aspergillus niger.

Kobbe, B, Cushman, M, Wogan, G N, Demain, A L

The production of the new mycotoxin malformin C by a solid substrate fermentation is described. Malformin C is highly toxic (mean lethal dose = 0.9 mg/kg) and exerts antibacterial activity against a...

Production and antibacterial activity of malforming C, a toxic metabolite of Aspergillus niger.

Kobbe, B, Cushman, M, Wogan, G N, Demain, A L

The production of the new mycotoxin malformin C by a solid substrate fermentation is described. Malformin C is highly toxic (mean lethal dose = 0.9 mg/kg) and exerts antibacterial activity against a...

Collaborative meta-analysis of prospective studies of plasma fibrinogen and cardiovascular disease

Kostis, J.B., Wilson, A.C., Folsom, A.R., Chambless, L., Wu, K., Benderly, M., ...

Background Many long-term studies have reported on associations of plasma fibrinogen concentration with cardiovascular disease, but few have been large enough to provide reliable estimates in...

Investigation of the alkenyldiarylmethane non-nucleoside reverse transcriptase inhibitors as potential cAMP phosphodiesterase-4B2 inhibitors

Cullen, M.D., Cheung, Y.F., Houslay, M.D., Hartman, T.L., Watson, K.M., Buckheit, R.W., ...

The alkenyldiarylmethanes (ADAMs) are currently being investigated as non- nucleoside HIV- 1 reverse transcriptase inhibitors (NNRTIs) of potential value in the treatment of HIV infection and AIDS....

Incidence and predictors of coronary heart disease among older African Americans--the Cardiovascular Health Study.

Jackson, S. A., Burke, G. L., Thach, C., Cushman, M., Ives, D., Powe, N., ...

Although coronary heart disease (CHD) is the leading cause of death and morbidity in older African Americans, relatively little is known about the incidence and predictors of CHD in this population....